Cision PR Newswire

Accident Accident Air Pollution All News Annoucement Argriculture Art ASEAN Book

Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy

First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease. Paired muscle biopsies reveal 3.5- to 5.3-fold increases in sarcolemmal utrophin expression, accompanied by definitive tissue histopathological...

Vatrer Power to Showcase Lithium Golf Cart Battery Conversion Kits at 2026 Golf Carting Expo & Dealer Summit

LAS VEGAS and CHARLESTON, S.C., Oct. 3, 2026 /PRNewswire/ -- Vatrer Power, a provider...

Cision PR Newswire

Poly Auction Hong Kong Autumn Auctions 2026 Preview Now Open: Four Collecting Categories Bring Together Art Across Eras and East and West

2–4 October 2026 | Preview5–7 October 2026 | Auctions Six Pacific Place, Hong...

Cision PR Newswire

Property Management of Chulalongkorn University Shapes a Sustainable District Through Shared Value and Innovation

BANGKOK, Oct. 3, 2026 /PRNewswire/ -- A thriving district is more than the buildings...

Cision PR Newswire

PEA Powers Thailand’s Sustainable Energy Future Through a Brand Built on Trust, Innovation, and Meaningful Impact

BANGKOK, Oct. 3, 2026 /PRNewswire/ -- A trusted brand is built through every interaction,...

Cision PR Newswire

OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution

AMSTERDAM, Aug. 4, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI), ("OCI," the "Company") announces today that it will pay a USD 700 million distribution (USD...

Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

HONG KONG, Aug. 4, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that its global, multicenter, randomized Phase II registrational trial...

Cision PR Newswire

Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy

Vatrer Power to Showcase Lithium Golf Cart Battery Conversion Kits at 2026 Golf Carting Expo & Dealer Summit

Poly Auction Hong Kong Autumn Auctions 2026 Preview Now Open: Four Collecting Categories Bring Together Art Across Eras and East and West

Property Management of Chulalongkorn University Shapes a Sustainable District Through Shared Value and Innovation

PEA Powers Thailand’s Sustainable Energy Future Through a Brand Built on Trust, Innovation, and Meaningful Impact

ABOUT US

FOLLOW US